David M. Brown, MD, is Clinical Professor of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine and vice-chair for research at the Blanton Eye Institute, Houston Methodist Hospital. He is the Director of Clinical Research at the Greater Houston Retina Research Center and in private practice at Retina Consultants of Houston. Dr. Brown graduated from Baylor College of Medicine with highest honors and completed ophthalmology and retina training at the University of Iowa where he was a Thomas Heed Fellow, a Hermann Knapp Fellow, and was awarded the Ron Michels Fellowship award presented to the top retinal surgery fellow in the US.

Dr Brown’s research and clinical interests are focused on macular surgery, AMD, gene therapy, retinal vascular disease, and diabetic retinopathy. Dr. Brown is an elected member of the Macula Society and the Retina Society and he directs one of the largest clinical trial centers for retinal disease in the US. Dr. Brown’s honors include the American Academy of Ophthalmology Honor Award in 2000, the AAO Senior Honor Award in 2014, and continuous election as one of the “Best Doctors in America” 2007 -2017. He has published and written over 400 national meeting presentations, abstracts, and scientific papers including many of the primary papers establishing the use of anti-VEGF agents for AMD, retinal vein occlusions, and diabetic retinopathy.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:

1. Bayer 
   
2. Regeneron 
   
3. Senju 
   
4. Adverum 
   
5. Regenxbio 
   
6. OHR Pharmaceutical Inc. 
   
7. Boehringer Ingelheim 
   
8. Novartis 
   
9. Heidelberg 
   
10. OPTOS 
    
11. Stealth Biotherapeutics 
    
12. Biotime 
    
13. Samsung 
    
14. Roche 
    
15. Genentech 
    
16. ChengduKanghong Biotechnology 
    
17. Merck 
    
18. Apellis 
    
19. Spark 
    
20. Allergan 
    
21. Clearside 
    
22. Tyrogenex 
    
23. National Eye Institute 
    
24. Opthotech